Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA): Upcoming Catalysts

August 15, 2016 8:31 AM
Guggenheim analyst Louise Chen, reiterated her Buy rating on shares of Teva Pharma (NYSE: TEVA) and highlighted some upcoming catalysts.After ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View

Next Articles